Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients

(2011) S R Park et al.   BRITISH JOURNAL OF CANCER

Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer

(2010) Kentaro Sudo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

S-1 Monotherapy as Second-line Treatment for Advanced Pancreatic Cancer after Gemcitabine Failure

(2010) A. Todaka et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer

(2009) Gyeong-Won Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

(2009) Do-Youn Oh et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

(2009) Elizabeth Poplin et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

(2009) David Cunningham et al.   JOURNAL OF CLINICAL ONCOLOGY

A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer

(2009) Yousuke Nakai et al.   ONCOLOGY

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

(2008) Volker Heinemann et al.   BMC CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1

(2008) Hidekazu Kuramochi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer

(2008) Chigusa Morizane et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)

(2008) A. Maeda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY